Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

April 1, 2004; Volume 45,Issue 4

SNM Newsline

  • You have access
    NRC Absorbed Dose Reconstruction for Family Member of 131I Therapy Patient: Case Study and Commentary
    Carol S. Marcus and Jeffry A. Siegel
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 13N-16N;
  • You have access
    New Features, Time-Honored Traditions Slated for SNM Annual Meeting in Philadelphia
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 19N-20N;
  • You have access
    186Re and High-Specific-Activity 177Lu Available in North America
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 22N;
  • You have access
    DOE Seeks Proposals
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 22N;
  • You have access
    HISTORY CORNER
    Henry N. Wagner
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 25N;
  • You have access
    SNM Leadership Update
    Virginia Pappas
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 26N;
  • You have access
    PUBLIC AFFAIRS UPDATE
    William Uffelman
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 27N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 28N-37N;
  • You have access
    Notification of Proposed Bylaws Changes
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 38N-50N;

Clinical Investigations

  • You have access
    Gated Myocardial SPECT to Predict Response to β-Blocker Therapy in Patients with Idiopathic Dilated Cardiomyopathy
    Kazuki Fukuchi, Yoshio Yasumura, Keisuke Kiso, Kohei Hayashida, Kunio Miyatake and Yoshio Ishida
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 527-531;
  • You have access
    Stress-Rest Myocardial Perfusion SPECT for Functional Assessment of Coronary Arteries with Anomalous Origin or Course
    Leonardo De Luca, Francesco Bovenzi, Domenico Rubini, Artor Niccoli-Asabella, Giuseppe Rubini and Italo de Luca
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 532-536;
  • You have access
    CT Attenuation Correction for Myocardial Perfusion Quantification Using a PET/CT Hybrid Scanner
    Pascal Koepfli, Thomas F. Hany, Christophe A. Wyss, Mehdi Namdar, Cyrill Burger, Alexander V. Konstantinidis, Thomas Berthold, Gustav K. von Schulthess and Philipp A. Kaufmann
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 537-542;
  • You have access
    Prospective Feasibility Trial of Radiotherapy Target Definition for Head and Neck Cancer Using 3-Dimensional PET and CT Imaging
    Christopher Scarfone, William C. Lavely, Anthony J. Cmelak, Dominique Delbeke, William H. Martin, Dean Billheimer and Dennis E. Hallahan
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 543-552;
  • You have access
    Scintimammography with Dedicated Breast Camera Detects and Localizes Occult Carcinoma
    Leonard R. Coover, Gina Caravaglia and Phyllis Kuhn
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 553-558;
  • You have access
    Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients
    Heiko Schöder, Yusuf E. Erdi, Kenneth Chao, Mithat Gonen, Steven M. Larson and Henry W.D. Yeung
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 559-566;
  • You have access
    Preparation of Patients with Thyroid Cancer for 131I Scintigraphy or Therapy by 1–3 Weeks of Thyroxine Discontinuation
    Perry W. Grigsby, Barry A. Siegel, Simon Bekker, William E. Clutter and Jeffrey F. Moley
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 567-570;
  • You have access
    Influence of Radioimmunoscintigraphy on Postprostatectomy Radiotherapy Treatment Decision Making
    Ashesh B. Jani, Michael J. Blend, Russell Hamilton, Charles Brendler, Charles Pelizzari, Lani Krauz, Srinivasan Vijayakumar, Bipin Sapra, Azhar Awan and Ralph R. Weichselbaum
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 571-578;
  • You have access
    PET and SPECT for Detection of Tumor Progression in Irradiated Low-Grade Astrocytoma: A Receiver-Operating-Characteristic Analysis
    Marcus Henze, Ashour Mohammed, Heinz P. Schlemmer, Klaus K. Herfarth, Simone Hoffner, Sabine Haufe, Walter Mier, Michael Eisenhut, Jürgen Debus and Uwe Haberkorn
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 579-586;
  • You have access
    Elimination of the Influence of Total Renal Function on Renal Output Efficiency and Normalized Residual Activity
    Cyril C. Nimmon, Martin Šámal and Keith E. Britton
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 587-593;

Brief Communications

  • You have access
    The Radiotoxicity of 131I Therapy of Thyroid Cancer: Assessment by Micronucleus Assay of B Lymphocytes
    Naoto Watanabe, Hirokazu Kanegane, Seigo Kinuya, Noriyuki Shuke, Kunihiko Yokoyama, Hiroshi Kato, Gakuto Tomizawa, Masashi Shimizu, Hisashi Funada and Hikaru Seto
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 608-611;

Continuing Education

  • You have access
    Brain 18F-FDG PET in the Diagnosis of Neurodegenerative Dementias: Comparison with Perfusion SPECT and with Clinical Evaluations Lacking Nuclear Imaging
    Daniel H.S. Silverman
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 594-607;

Basic Science Investigations

  • You have access
    Biologic Dosimetry of 188Re-HDD/Lipiodol Versus 131I-Lipiodol Therapy in Patients with Hepatocellular Carcinoma
    Kim De Ruyck, Bieke Lambert, Klaus Bacher, Filip Gemmel, Filip De Vos, Anne Vral, Leo de Ridder, Rudi A. Dierckx and Hubert Thierens
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 612-618;
  • You have access
    Impact of 131I Diagnostic Activities on the Biokinetics of Thyroid Remnants
    Michael Lassmann, Markus Luster, Heribert Hänscheid and Christoph Reiners
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 619-625;
  • You have access
    Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone
    Willy-Anne Nieuwlaat, Ad R. Hermus, H. Alec Ross, Wilhelmina C. Buijs, Michela A. Edelbroek, Jo W. Bus, Frans H. Corstens and Dyde A. Huysmans
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 626-633;
  • You have access
    Proposed Addendum to Previously Published Fetal Dose Estimate Tables for 18F-FDG
    Michael G. Stabin
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 634-635;
  • You have access
    Tetraphenylphosphonium as a Novel Molecular Probe for Imaging Tumors
    Jung-Jun Min, Sandip Biswal, Christophe Deroose and Sanjiv S. Gambhir
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 636-643;
  • You have access
    Quantitation of Pulmonary Transgene Expression with PET Imaging
    Jean-Christophe Richard, Zhaohui Zhou, Delphine L. Chen, Mark A. Mintun, David Piwnica-Worms, Phillip Factor, Datta E. Ponde and Daniel P. Schuster
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 644-654;
  • You have access
    Early Detection of Infarct in Reperfused Canine Myocardium Using 99mTc-Glucarate
    David R. Okada, Gerald Johnson, Zhonglin Liu, Sonia D. Hocherman, Ban-An Khaw and Robert D. Okada
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 655-664;
  • You have access
    Measurement of Cerebral Glucose Metabolic Rates in the Anesthetized Rat by Dynamic Scanning with 18F-FDG, the ATLAS Small Animal PET Scanner, and Arterial Blood Sampling
    Kazuaki Shimoji, Laura Ravasi, Kathleen Schmidt, Maria Luisa Soto-Montenegro, Takanori Esaki, Jurgen Seidel, Elaine Jagoda, Louis Sokoloff, Michael V. Green and William C. Eckelman
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 665-672;
  • You have access
    Characterization of the Binding Sites for 123I-ADAM and the Relationship to the Serotonin Transporter in Rat and Mouse Brains Using Quantitative Autoradiography
    Kun-Ju Lin, Tzu-Chen Yen, Shiaw-Pyng Wey, Jeng-Jong Hwang, Xin-Xian Ye, Kai-Yuan Tzen, Ying-Kai Fu and Jin-Chung Chen
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 673-681;
  • You have access
    Comparative Evaluation of Serotonin Transporter Radioligands 11C-DASB and 11C-McN 5652 in Healthy Humans
    W. Gordon Frankle, Yiyun Huang, Dah-Ren Hwang, Peter S. Talbot, Mark Slifstein, Ronald Van Heertum, Anissa Abi-Dargham and Marc Laruelle
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 682-694;
  • You have access
    Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model
    Aren van Waarde, David C.P. Cobben, Albert J.H. Suurmeijer, Bram Maas, Willem Vaalburg, Erik F.J. de Vries, Pieter L. Jager, Harald J. Hoekstra and Philip H. Elsinga
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 695-700;
  • You have access
    A Kit Formulated Under Good Manufacturing Practices for Labeling Human Epidermal Growth Factor with 111In for Radiotherapeutic Applications
    Raymond M. Reilly, Deborah A. Scollard, Judy Wang, Hridya Mondal, Paul Chen, Lee A. Henderson, Barry M. Bowen and Katherine A. Vallis
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 701-708;
  • You have access
    Uptake of [111In-DTPA0]Octreotide in the Rat Kidney Is Inhibited by Colchicine and Not by Fructose
    Edgar J. Rolleman, Eric P. Krenning, Arthur van Gameren, Bert F. Bernard and Marion de Jong
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 709-713;
  • You have access
    A Lesion Detection Observer Study Comparing 2-Dimensional Versus Fully 3-Dimensional Whole-Body PET Imaging Protocols
    Carole Lartizien, Paul E. Kinahan and Claude Comtat
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 714-723;

Departments

  • You have access
    Erratum
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 558;

Letters to the Editor

  • You have access
    A Simple Interpretation of Fractal Analysis of Images
    Joseph A. Thie
    Journal of Nuclear Medicine April 1, 2004, 45 (4) 724;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 45 (4)
Journal of Nuclear Medicine
Vol. 45, Issue 4
April 1, 2004
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • SNM Newsline
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Departments
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire